Mint Cannabis Expands Into Florida, Bringing the Brand Closer to South Florida Patients

Mint Cannabis, a fast-growing multistate dispensary operator best known for its large-footprint retail stores in the West, is officially planting its flag in Florida—an expansion that includes a new Delray Beach location positioned as one of the closest Mint-branded options for patients traveling from South Florida population centers like Fort Lauderdale and Miami. The company said the Florida move is part of a broader rollout of 18 community-focused medical dispensaries across the state.

In a release announcing the Florida expansion, Mint Cannabis said 13 dispensaries are already open statewide, listing Delray Beach among the first wave of operating locations. The company also said five additional Florida dispensaries—including a Miami site—are expected to open “in the coming months,” with more planned by the end of 2026.

For South Florida, the Delray Beach storefront matters because it sits on the main east–west commercial corridor of West Atlantic Avenue, offering a drivable option for patients in Broward County and northern Miami-Dade who may be looking for additional selection, promotions, or an alternative to entrenched incumbents. Mint’s Delray Beach page lists the dispensary at 6110 W Atlantic Ave, Delray Beach, FL 33484, with daily operating hours posted for consumers.

Mint’s Florida entry is tied to a major transaction that reshaped assets previously operated under The Cannabist Company banner. In late 2024, The Cannabist Company announced the closing of the sale of its 14 Florida dispensaries and two cultivation and manufacturing facilities (in Alachua and Arcadia) to a joint venture between Mint Cannabis and Shango—a deal that laid the operational groundwork for rebranding and expansion under Mint’s retail model.

Mint is framing the Florida buildout as a local-employment- and education-driven approach rather than a purely transactional market entry. “Florida represents an exciting new chapter for the Mint…,” said Rudy Molina, the company’s vice president of operations, adding that the brand aims to invest in community relationships through hiring, support, and patient education.

The timing is significant. Florida remains one of the country’s largest medical cannabis markets by patient count and retail sales, but it is also highly competitive and operationally complex, shaped by state licensing rules and vertical integration requirements. Mint’s initial footprint—spanning cities from Jacksonville and Gainesville to Cape Coral and Sarasota—signals an attempt to scale quickly with broad geographic coverage while still placing strategic outposts near major metros. Delray Beach, in particular, functions as a gateway between Palm Beach County and the Fort Lauderdale–Miami corridor, which could make it a convenient “closest Mint” stop for many South Florida patients until the brand’s planned Miami location fully ramps up.

For consumers, the near-term question will be whether Mint can differentiate on pricing, product assortment, and in-store experience—especially in a market where loyalty programs, delivery logistics, and consistent inventory often determine who wins repeat business. Mint’s next openings, including Miami, will be closely watched as the company tests whether its big-market playbook translates to Florida’s uniquely regulated, medical-only landscape.